Compare TECH & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | KRMD |
|---|---|---|
| Founded | 1976 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 195.7M |
| IPO Year | 1995 | 2019 |
| Metric | TECH | KRMD |
|---|---|---|
| Price | $53.49 | $4.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $73.09 | $6.50 |
| AVG Volume (30 Days) | ★ 2.1M | 136.9K |
| Earning Date | 05-06-2026 | 03-12-2026 |
| Dividend Yield | ★ 0.61% | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $1,219,635,000.00 | $41,127,366.00 |
| Revenue This Year | $2.49 | $20.32 |
| Revenue Next Year | $6.40 | $17.38 |
| P/E Ratio | $106.41 | ★ N/A |
| Revenue Growth | 5.23 | ★ 22.23 |
| 52 Week Low | $46.02 | $1.87 |
| 52 Week High | $72.16 | $6.61 |
| Indicator | TECH | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.49 | 40.41 |
| Support Level | $49.30 | $4.08 |
| Resistance Level | $56.56 | $4.34 |
| Average True Range (ATR) | 2.02 | 0.20 |
| MACD | 0.52 | 0.02 |
| Stochastic Oscillator | 88.29 | 45.24 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.